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Food allergy is an important public health problem because it affects children and 82 
adults, it may be severe and even life-threatening, and it may be increasing in prevalence.  83 
Beginning in 2008, the National Institute of Allergy and Infectious Diseases (NIAID), 84 
working with other organizations and advocacy groups, led the development of the first 85 
clinical guidelines for the diagnosis and management of food allergy. These guidelines,1
   89 
 86 
which were published in 2010, did not offer strategies for the prevention of food allergy 87 
due to a lack of definitive studies at the time.  88 
In February 2015, the New England Journal of Medicine published the results of 90 
the “Learning Early about Peanut Allergy” (LEAP) trial.  This landmark clinical trial 91 
showed that introduction of peanut products into the diets of infants at high risk of 92 
developing peanut allergy was safe and led to an 81 percent relative reduction in the 93 
subsequent development of peanut allergy. The LEAP trial results, combined with other 94 
emerging data, strongly suggested that peanut allergy can be prevented through 95 
introduction of peanut-containing foods beginning in infancy. This growing body of 96 
evidence raised the need for clinical recommendations focusing on peanut allergy 97 
prevention.   98 
 99 
To achieve this goal and its wide implementation, NIAID invited the members of 100 
the 2010 Guidelines Coordinating Committee and other stakeholder organizations to 101 
develop this addendum on peanut allergy prevention to the 2010 Guidelines for the 102 
Diagnosis and Management of Food Allergy in the United States.   103 
 104 
DEVELOPMENT OF THE 201 7 ADDENDUM TO THE 2010 GUIDELINES FOR 105 
THE DIAGNOSIS AND MANAGEMENT OF FOOD ALLERGY  106 
 107 
Coordinating Committee  108 
The NIAID established a Coordinating Committee (CC), whose members are 109 
listed in Appendix A, to oversee the development of the addendum; review drafts of the 110 
addendum for accuracy, practicality, clarity, and broad utility of the recommendations in 111 















Togias et al                                                                                                                                        5 
 
This article is protected by copyright. All rights reserved 
The CC members represented 26 professional organizations, advocacy groups, and 113 
federal agencies.  114 
Expert Panel 115 
In June 2015, the CC convened an Expert Panel (EP) that was chaired by Joshua 116 
Boyce, MD. The 26 panel members, listed in Appendix B, were specialists from a variety 117 
of relevant clinical, scientific, and public health areas.  Panel members were nominated 118 
by the CC organizations, and the composition of the panel received unanimous approval 119 
by the CC member organizations.   120 
The charge to the EP was to use the literature review prepared by the NIAID, in 121 
conjunction with consensus expert opinion and EP-identified supplementary documents, 122 
to develop evidence-based recommendations for the early introduction of dietary peanut 123 
to prevent peanut allergy. The new guidelines are intended to supplement and modify 124 
Guidelines 37 to 40 in Section 5.3.4 of the 2010 Guidelines:1
Literature r eview 127 
 “Prevention of Food 125 
Allergy.” 126 
NIAID staff conducted a literature search of PubMed, limited to the years 2010 128 
(January) to 2016 (June). Sixty four publications (original research articles, 129 
editorials/letters, and systematic reviews) were deemed relevant and placed into 2 tiers: 130 
tier 1 contained 18 items, considered highly relevant to the early introduction of peanut or 131 
other allergenic foods; and tier 2 contained 46 items on related topics such as food allergy 132 
or eczema prevention.   133 
Assessing the quality of the body of evidence 134 
For the tier 1 references, the EP assessed the quality using the Grading of 135 
Recommendations Assessment, Development and Evaluation (GRADE) approach.  136 
Preparation of the addendum  137 
Draft versions of the addendum were reviewed by the CC members, open to 138 
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 140 
DEFINING  THE STRENGTH OF EACH CLINICAL GUIDELINE  141 
The EP has used the verb “recommends” or “suggests” for each clinical 142 
recommendation.  These words convey the strength of the recommendation, defined as 143 
follows: 144 
• Recommend is used when the EP strongly recommended for or against a particular 145 
course of action.  146 
• Suggest is used when the EP weakly recommended for or against  particular 147 
course of action.  148 
 149 
ADDENDUM GUIDELINES  150 
The EP came to consensus on the following 3 definitions used throughout the addendum 151 
guidelines. 152 
• Severe eczema is defined as persistent or frequently recurring eczema with typical 153 
morphology and distribution assessed as severe by a health care provider and 154 
requiring frequent need for prescription-strength topical corticosteroids, 155 
calcineurin inhibitors, or other anti-inflammatory agents despite appropriate use 156 
of emollients. 157 
• Egg allergy is defined as a history of an allergic reaction to egg and a skin prick 158 
test (SPT) wheal diameter of 3 mm or greater with egg white extract, or a positive 159 
oral egg food challenge r sult.  160 
• A specialist is defined as ahealth care provider with the training and experience 161 
to (1) perform and interpret SPTs and oral food challenges (OFC) and (2) know 162 
and manage their risks.  Such persons must have appropriate medications and 163 
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Addendum 
guideline 





allergy, or both 
Strongly consider evaluation by 
sIgE and/or SPT and, if 
necessary, an oral food 










Around 6 months 











Addendum guideline 1   172 
The EP recommends that infants with severe eczema, egg allergy, or both have 173 
introduction of age-appropriate peanut-containing food as early as 4 to 6 months of age to 174 
reduce the risk of peanut allergy.  Other solid foods should be introduced before peanut-175 
containing foods to show that the infant is developmentally ready.  The EP recommends 176 
that evaluation with peanut-specific IgE (peanut sIgE) measurement, SPTs, or both be 177 
strongly considered before introduction of peanut to determine if peanut should be 178 
introduced and, if so, the preferred method of introduction.  To minimize a delay in 179 
peanut introduction for children who may test negative, testing for peanut sIgE may be 180 
the preferred initial approach in certain health care settings, such as family medicine, 181 
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Alternatively, referral for assessment by a specialist maybe an option if desired by the 183 









Recommended approaches for evaluation of children with severe eczema and/or egg 193 









Risk of reaction low. 
Over 90% will have (-) SPT to 
peanut. 
Options:  
a) Introduce peanut at home 
b) Supervised feeding in the 
office  
(based on provider/ parental 
preference) 
≥0.35 
Refer to specialist for 
consultation/SPT protocol 
Peanut Skin Prick Test 
0-2 mm 
Risk of reaction low 




a) Introduce peanut at 
home 
b) Supervised feeding 





Risk of reaction varies 
from moderate to 
high. 
Options: 
a) Supervised feeding 
in office 










*To minimize a delay in peanut introduction for children who may test negative, testing for peanut-
specific IgE may be the preferred initial approach in certain healt  care settings.  Food allergen panel 
testing or the addition of sIgE testing for foods other than peanut is o recommended due to poor 
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f the 206 
decision is made to introduce dietary peanut based on the recommendations of addendum 207 
guideline 1, the total amount of peanut protein to be regularly consumed per week should 208 
be approximately 6 to 7 grams over 3 or more feedings.  209 
Quality of evidence. Moderate.       210 
The designation of the quality of evidence as “moderate” (as opposed to “high”) is 211 
based on the fact that this recommendation derives primarily from a single radomized, 212 
open-label study: the LEAP trial.  However, it should be noted that the assessment of the 213 
LEAP trial’s primary outcome was based on a double-blind, placebo-controlled OFC.  214 
Furthermore, confidence in this recommendation is bolstered by the large effect size 215 
demonstrated in the LEAP trial and prior epidemiological data that peanut allergy is 216 
relatively infrequent in Israel, where early childhood consumption of peanut is common.  217 
Contribution of expert opinion. Significant. 218 
Additional comments.  219 
1) Breast-feeding recommendations: The EP recognizes that early introduction of 220 
peanut may seem to depart from recommendations for exclusive breast-feeding 221 
through 6 months of age. However, it should be noted that data from the nutrition 222 
analysis of the LEAP cohort indicate that introduction of peanut did not affect the 223 
duration or frequency of breast-feeding, and did not influence growth or nutrition. 224 
2) Age of peanut introduction: For children with severe eczema, egg allergy, or both, 225 
the EP recommends that introduction of solid foods begins at 4 to 6 months of age, 226 
Important considerations for skin prick testing 
SPT reagents, testing devices, and methodology can differ significantly among health 
care providers in the United States or elsewhere. The EP recommends that specialists 
should adjust their SPT categorization criteria according to their own training and 
experience. 
Health care providers conducting oral food challenges in infants with 3 mm or greater 
SPT responses hould be aware that the probability of a positive challenge increases 
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starting with solid food other than peanut. However, it is important to note that the 227 
infants in the LEAP trial were enrolled between 4 and 11 months of age and 228 
benefitted from peanut consumption regardless of age at entry.  Therefore, if the 229 
4- to 6-month time window is missed for any reason, including developmental 230 
delay, infants may still benefit from early peanut introduction.  231 
3) Considerations for family members with established peanut allergy: The EP 232 
recognizes that many infants eligible for early peanut introduction under this 233 
guideline will have older siblings or caregivers with established peanut allergy.  234 
The EP recommends that in this situation caregivers discuss with their health care 235 
providers the overall benefit (reduced risk of peanut allergy in the infant) versus 236 
risks (potential for further sensitization and accidental exposure of the family 237 
member to peanut) of adding peanut to the infant’s diet.  238 
4) Children identified as allergic to peanut: For children who have been identified as 239 
allergic to peanut, the EP recommends strict peanut avoidance.  This may include 240 
those children who fail the supervised peanut feeding or the OFC, or those 241 
children who, upon further evaluation by a specialist, are confirmed as being 242 
allergic to peanut. These children should be under long-term management by a 243 
specialist. 244 
 245 
Addendum guideline 2 246 
The EP suggests that infats with mild-to-moderate eczema should have introduction 247 
of age-appropriate peanut-containing food around 6 months of age, in accordance with 248 
family preferences and cultural practices, to reduce the risk of peanut allergy. Other solid 249 
foods should be introduced before peanut-containing foods to show that the infant is 250 
developmentally ready.  The EP recommends that infants in this category may have 251 
dietary peanut introduced at home without an in-office evaluation.  However, the EP 252 
recognizes that some caregivers and healt care providers may desire an in-office 253 
supervised feeding, evaluation, or both.  254 
Quality of evidence. Low.  255 
The quality of evidence is low because this recommendation is based on extrapolation 256 















Togias et al                                                                                                                                        11 
 
This article is protected by copyright. All rights reserved 
Contribution of expert opinion. Significant. 258 
 259 
Addendum guideline 3 260 
The EP suggests that infants without eczema or any food allergy have age-appropriate 261 
peanut-containing foods freely introduced in the diet together with other solid foods and 262 
in accordance with family preferences and cultural practices.  263 
Quality of evidence. Low.      264 
Contribution of expert opinion. Significant. 265 
 266 
Reference 267 
1. Boyce JA, Assa'ad A, Burks AW, Jones SM, Sampson HA, Wood RA, et al.  268 
Guidelines for the diagnosis and management of food allergy in the United States: 269 
report of the NIAID-sponsored expert panel. J Allergy Clin Immunol 270 
2010;126(suppl):S1-58. 271 
APPENDIX A.  COORDINATING COMMITTEE MEMBER 272 
ORGANIZATIONS AND REPRESENTATIVES  273 
 274 
Academy of Nutrition and Dietetics 275 
http://www.eatright.org/ 276 
Alison Steiber PhD, RD 277 
 278 
Allergy & Asthma Network Mothers of Asthmatics (AANMA)  279 
http://www.allergyasthmanetwork.org/main/ 280 
Tonya A. Winders, MBA 281 
 282 
American Academy of Allergy, Asthma & Immunology (AAAAI) 283 
https://www.aaaai.org/home.aspx 284 
Hugh A. Sampson, MD 285 
















Togias et al                                                                                                                                        12 
 
This article is protected by copyright. All rights reserved 
American Academy of Family Physicians (AAFP) 288 
http://www.aafp.org/home.html 289 
Jason Matuszak, MD 290 
 291 
American Academy of Dermatology (AAD) 292 
https://www.aad.org/ 293 
Lawrence F. Eichenfield, MD, FAAD 294 
Jon Hanifin, MD  295 
 296 
American Academy of Emergency Medicine (AAEM) 297 
http://www.aaem.org/ 298 
Joseph P.  Wood, MD, JD 299 
 300 
American Academy of Pediatrics (AAP) 301 
https://www.aap.org 302 
Scott H. Sicherer, MD, FAAP 303 
 304 
American Academy of Physician Assistants (AAPA) 305 
https://www.aapa.org/ 306 
Gabriel Ortiz, MPAS, PA-C, DFAAPA 307 
 308 
American College of Allergy, Asthma and Immunology (ACAAI) 309 
http://acaai.org/ 310 
Amal Assa’ad, MD 311 
 312 
American College of Gastroenterology (ACG) 313 
http://gi.org/ 314 
Steven J. Czinn, MD, FACG 315 
 316 
















Togias et al                                                                                                                                        13 
 
This article is protected by copyright. All rights reserved 
Wendy Book, MD 319 
 320 
American Society for Nutrition (ASN) 321 
http://www.nutrition.org/ 322 
George J. Fuchs, III, MD 323 
 324 
Asthma and Allergy Foundation of America (AAFA) 325 
http://www.aafa.org/ 326 
Meryl Bloomrosen, MBA, MBI 327 
David R. Stukus, MD 328 
 329 
Canadian Society of Allergy and Clinical Immunology (CSACI) 330 
http://www.csaci.ca/ 331 
Edmond Chan, MD, FRCPC 332 
 333 
Eunice Kennedy Shriver National Institute of Child Health & Human Development 334 
(NICHD)  335 
https://www.nichd.nih.gov 336 
Gilman Grave, MD 337 
 338 
European Academy of Allergy and Clinical Immunology (EAACI) 339 
http://www.eaaci.org/ 340 
Antonella Muraro, MD, PhD 341 
 342 
Food Allergy Research & Education (FARE) 343 
https://www.foodallergy.org/ 344 
James R. Baker, MD 345 
Mary Jane Marchisotto  346 
 347 
















Togias et al                                                                                                                                        14 
 
This article is protected by copyright. All rights reserved 
Julie Block 350 
 351 
National Heart, Lung, and Blood Institute (NHLBI)  352 
http://www.nhlbi.nih.gov/ 353 
Janet M. de Jesus, MS, RD 354 
 355 
National Institute of Allergy and Infectious Diseases (NIAID) 356 
http://www.niaid.nih.gov/ 357 
Daniel Rotrosen, MD 358 
Alkis Togias, MD 359 
Marshall Plaut, MD 360 
 361 
National Institute of Arthri tis and Musculoskeletal and Skin Diseases (NIAMS) 362 
http://www.niams.nih.gov/ 363 
Ricardo Cibotti, PhD 364 
 365 
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 366 
www.niddk.nih.gov 367 
Frank Hamilton, MD, MPH 368 
Margaret A. McDowell, PhD, MPH, RD (retired) 369 
Rachel Fisher, MS, MPH, RD 370 
 371 
North American Society for Pediatric Gastroenterology, Hepatology and Nutrit on 372 
(NASPGHAN)  373 
http://www.naspghan.org/ 374 
Glenn Furuta, MD 375 
 376 
Society of Pediatric Nurses (SPN)  377 
http://www.pedsnurses.org/ 378 
















Togias et al                                                                                                                                        15 
 
This article is protected by copyright. All rights reserved 
United States Department of Agriculture (USDA) 381 
http://www.usda.gov/ 382 
Soheila J. Maleki, PhD 383 
 384 
World Allergy Organization (WAO) 385 
http://www.worldallergy.org/ 386 
Lanny J. Rosenwasser, MD 387 
APPENDIX B: EXPERT PANEL, JUNE 2015 388 
 389 
Chair  390 
Joshua A. Boyce, MD 391 
Professor of Medicine and Pediatrics 392 
Harvard Medical School  393 
Director, Inflammation and Allergic Disease Research Section 394 
Director, Jeff and Penny Vinik Center for Allergic Disease Research 395 
Specialty: Allergy/pediatric pulmonology 396 
 397 
Panelists 398 
Maria Acebal, JD 399 
Board of Directors, Food Allergy Research & Education 400 
Member of NIAID Advisory Council 401 
Former CEO of Food Allergy and Anaphylaxis Network 402 
Specialty: Advocacy 403 
 404 
Amal Assa'ad, MD 405 
Professor, University of Cincinnati Department of Pediatrics  406 
Director, FARE Center of Excellence in Food Allergy 407 
Director of Clinical Services, Division of Allergy and Immunology 408 
Associate Director, Division of Allergy and Immunology 409 
Cincinnati Children’s Hospital Medical Center 410 















Togias et al                                                                                                                                        16 
 
This article is protected by copyright. All rights reserved 
 412 
James R. Baker Jr, MD 413 
CEO and Chief Medical Officer 414 
Food Allergy Research & Education, McLean VA  415 
Founding Director, Mary H. Weiser Food Allergy Center, University of Michigan 416 
Professor of Internal Medicine, Division of Allergy and Clinical Immunology 417 
University of Michigan Health System 418 
Specialty: Allergy/advocacy/education 419 
 420 
Lisa A. Beck, MD 421 
Professor, Department of Dermatology  422 
University of Rochester Medical Center 423 
School of Medicine and Dentistry 424 
Specialty: Dermatology 425 
 426 
Julie Block 427 
President and CEO 428 
National Eczema Association 429 
Specialty: Advocacy/education 430 
 431 
Carol Byrd- Bredbenner, PhD, RD, FAND 432 
Professor of Nutrition/Extension Specialist 433 
Rutgers University, School of Environmental and Biological Sciences 434 
Specialty: Nutrition/health communication/behavioral science 435 
 436 
Edmond S. Chan, MD, FRCPC 437 
Clinical Associate Professor 438 
Head, Division of Allergy and Immunology  439 
Department of Pediatrics 440 
BC Children's Hospital 441 















Togias et al                                                                                                                                        17 
 
This article is protected by copyright. All rights reserved 
Specialty: Allergy/pediatrics 443 
 444 
Lawrence F. Eichenfield, MD 445 
Professor of Pediatrics and Dermatology 446 
Chief, Pediatric and Adolescent Dermatology 447 
Rady Children's Hospital, San Diego 448 
University of California, San Diego School of Medicine 449 
Specialty: Dermatology/pediatrics 450 
 451 
David M. Fleischer, MD  452 
Associate Professor of Pediatrics 453 
University of Colorado School of Medicine 454 
Children’s Hospital Colorado, Aurora, CO 455 
Specialty: Allergy/pediatrics 456 
 457 
George J. Fuchs III, MD 458 
Professor of Pediatrics  459 
University of Kentucky College of Medicine 460 
Chief, Gastroenterology, Nutrition & Hepatology 461 
Kentucky Children’s Hospital 462 
Specialty: Gastroenterology/pediatrics 463 
 464 
Glenn T. Furuta, MD 465 
Professor of Pediatrics 466 
Director, Gastrointestinal Eosinophilic Diseases Program 467 
University of Colorado School of Medicine 468 
Children’s Hospital Colorado, Aurora, CO 469 
Specialty: Gastroenterology/pediatrics 470 
 471 
Matthew J. Greenhawt, MD MBA, MSc 472 















Togias et al                                                                                                                                        18 
 
This article is protected by copyright. All rights reserved 
Allergy Section 474 
University of Colorado School of Medicine 475 
Children's Hospital Colorado, Aurora, CO 476 
Specialty: Allergy/pediatrics 477 
 478 
Ruchi Gupta, MD, MPH 479 
Associate Professor of Pediatrics and Medicine  480 
Director, Food Allergy Outcomes Research Program 481 
Ann and Robert H. Lurie Children's Hospital of Chicago 482 
Northwestern Medicine, Northwestern University 483 
Specialty: Pediatrics 484 
 485 
Michele Habich, DNP, APN/CNS, CPN  486 
Advanced Practice Nurse 487 
Northwestern Medicine, Central DuPage Hospital 488 
Specialty: Nursing/pediatrics/education 489 
 490 
Stacie M. Jones, MD 491 
Professor of Pediatrics 492 
University of Arkansas for Medical Sciences  493 
Chief, Allergy and Immunology  494 
Arkansas Children’s Hospital 495 
Specialty: Allergy/pediatrics 496 
 497 
Kari Keaton  498 
Facilitator, Metro DC Food Allergy Support Group 499 
Specialty: Advocacy/education 500 
 501 
Antonella Muraro, MD, PhD 502 
President of European Academy of Allergy and Clinical Immunology (EAACI) 503 















Togias et al                                                                                                                                        19 
 
This article is protected by copyright. All rights reserved 
Head of the Veneto Region Food Allergy Centre of Excellence for Research and 505 
Treatment 506 
University Hospital of Padua, Italy 507 
Specialty: Allergy/pediatrics 508 
 509 
Lanny J. Rosenwasser, MD 510 
Immediate Past President, World Allergy Organization 511 
Professor of Medicine 512 
University of Missouri-Kansas City-School of Medicine 513 
Specialty: Allergy/pediatrics 514 
 515 
Hugh A. Sampson, MD 516 
Professor of Pediatrics, Allergy and Immunology 517 
Icahn School of Medicine at Mount Sinai 518 
Director, Jaffe Food Allergy Institute  519 
Specialty: Allergy/pediatrics 520 
 521 
Lynda C. Schneider, MD 522 
Professor of Pediatrics 523 
Harvard Medical School 524 
Director, Allergy Program 525 
Boston Children’s Hospital 526 
Specialty: Allergy/pediatrics 527 
 528 
Scott H.  Sicherer, MD 529 
Professor Pediatrics, Allergy and Immunology 530 
Icahn School of Medicine at Mount Sinai 531 
Division Chief, Pediatric Allergy and Immunology 532 
Specialty: Allergy/pediatrics 533 
 534 















Togias et al                                                                                                                                        20 
 
This article is protected by copyright. All rights reserved 
Professor 536 
Department of Pediatrics 537 
Chief, Division of Dermatology 538 
Seattle Children’s Hospital 539 
University of Washington School of Medicine 540 
Specialty: Dermatology/pediatrics 541 
 542 
Jonathan Spergel, MD, PhD 543 
Stuart Starr Professor of Pediatrics 544 
Chief, Allergy Section 545 
Director, Center for Pediatric Eosinophilic Disorders 546 
The Children’s Hospital of Philadelphia 547 
Perelman School of Medicine, University of Pennsylvania 548 
Specialty: Allergy/pediatrics 549 
 550 
David R. Stukus, MD 551 
Assistant Professor of Pediatrics 552 
Section of Allergy/Immunology 553 
Nationwide Children’s Hospital 554 
Columbus, OH 555 
Specialty: Allergy/pediatrics 556 
 557 
Carina Venter, PhD, RD 558 
Allergy Specialist, Dietitian  559 
Cincinnati Children's Hospital Medical Center 560 
University of Cincinnati College of Medicine 561 
Specialty: Allergy/dietitian/pediatrics 562 
Abbreviations used 563 
CC: Coordinating Committee 564 
EP: Expert Panel 565 















Togias et al                                                                                                                                        21 
 
This article is protected by copyright. All rights reserved 
LEAP: Learning Early about Peanut Allergy 567 
NIAID:  National Institute of Allergy and Infectious Diseases  568 
OFC:  Oral food challenge 569 
sIgE:  Specific Immunoglobulin E 570 
SPT: Skin prick test 571 
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